Home/Filings/4/0001484612-24-000041
4//SEC Filing

Racine Jean-Olivier 4

Accession 0001484612-24-000041

CIK 0001484612other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 6:19 PM ET

Size

5.5 KB

Accession

0001484612-24-000041

Insider Transaction Report

Form 4
Period: 2024-05-10
Racine Jean-Olivier
Chief Technology Officer
Transactions
  • Sale

    Common Stock

    2024-05-10$3.27/sh8,306$27,161265,325 total
Footnotes (2)
  • [F1]Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting on May 10, 2024, of an aggregate of 33,923 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021, January 26, 2022 and January 6, 2023, which were subject to accelerated vesting approved by the Compensation Committee of the Board in connection with the reporting person's departure. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  • [F2]Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).

Issuer

Outset Medical, Inc.

CIK 0001484612

Entity typeother

Related Parties

1
  • filerCIK 0001868039

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 6:19 PM ET
Size
5.5 KB